Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bayer, J&J's Xarelto gets FDA priority review
Bayer, J&J's Xarelto gets FDA priority review
Bayer, J&J's Xarelto gets FDA priority review
Submitted by
admin
on July 9, 2012 - 9:12am
Source:
Reuters
News Tags:
Xarelto
pulmonary embolism
deep vein thrombosis
Bayer
JNJ
FDA
Headline:
Bayer, J&J's Xarelto gets FDA priority review
Do Not Allow Advertisers to Use My Personal information
